.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
QuintilesIMS
Chinese Patent Office
Deloitte
McKesson
Covington
McKinsey
Johnson and Johnson
Boehringer Ingelheim
US Army

Generated: July 20, 2017

DrugPatentWatch Database Preview

Carvedilol phosphate - Generic Drug Details

« Back to Dashboard

What are the generic sources for carvedilol phosphate and what is the scope of carvedilol phosphate freedom to operate?

Carvedilol phosphate
is the generic ingredient in one branded drug marketed by Smithkline Beecham and is included in one NDA. There are two patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are thirty-six drug master file entries for carvedilol phosphate. Three suppliers are listed for this compound.

Summary for Generic Name: carvedilol phosphate

Tradenames:1
Patents:2
Applicants:1
NDAs:1
Drug Master File Entries: see list36
Suppliers / Packagers: see list3
Bulk Api Vendors: see list96
Clinical Trials: see list907
Patent Applications: see list8,791
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:carvedilol phosphate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-002Oct 20, 2006RXYesNo8,101,209*PED► SubscribeY► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-003Oct 20, 2006RXYesYes8,101,209*PED► SubscribeY► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-004Oct 20, 2006RXYesNo7,268,156*PED► SubscribeY► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-001Oct 20, 2006RXYesNo7,268,156*PED► SubscribeY► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-003Oct 20, 2006RXYesYes7,268,156*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: carvedilol phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-002Oct 20, 20065,760,069*PED► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-001Oct 20, 2006RE40000*PED► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-003Oct 20, 20065,902,821*PED► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-004Oct 20, 2006RE40000*PED► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-001Oct 20, 20064,503,067*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
US Department of Justice
Deloitte
Fuji
Citi
Farmers Insurance
Chinese Patent Office
Medtronic
Moodys
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot